Holen Sie sich die Stockscreener-App
31.66
3.06%
0.94
Handel nachbörslich:
31.67
0.01
+0.03%
Schlusskurs vom Vortag:
$30.72
Offen:
$30.96
24-Stunden-Volumen:
408.14K
Relative Volume:
0.50
Marktkapitalisierung:
$1.42B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-47.20M
KGV:
-20.23
EPS:
-1.5653
Netto-Cashflow:
$-43.65M
1W Leistung:
+3.63%
1M Leistung:
+10.39%
6M Leistung:
+138.40%
1J Leistung:
+118.19%
1-Tages-Spanne:
$30.52
$32.05
1-Wochen-Bereich:
$27.84
$34.40
52-Wochen-Spanne:
$4.8069
$35.55
Mbx Biosciences Inc Stock (MBX) Company Profile
Firmenname
Mbx Biosciences Inc
Sektor
Branche
Telefon
(317) 989-3100
Adresse
11711 N. MERIDIAN STREET, CARMEL
Vergleichen Sie MBX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MBX
Mbx Biosciences Inc
|
31.66 | 1.38B | 0 | -47.20M | -43.65M | -1.5653 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Mbx Biosciences Inc Stock (MBX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-04 | Eingeleitet | Goldman | Sell |
| 2025-11-04 | Eingeleitet | TD Cowen | Buy |
| 2025-10-15 | Eingeleitet | Truist | Buy |
| 2025-08-15 | Fortgesetzt | Jefferies | Buy |
| 2025-08-05 | Eingeleitet | Mizuho | Outperform |
| 2025-07-16 | Eingeleitet | Oppenheimer | Outperform |
| 2025-04-10 | Eingeleitet | Citizens JMP | Mkt Outperform |
| 2024-10-08 | Eingeleitet | Guggenheim | Buy |
| 2024-10-08 | Eingeleitet | JP Morgan | Overweight |
| 2024-10-08 | Eingeleitet | Jefferies | Buy |
| 2024-10-08 | Eingeleitet | Stifel | Buy |
Alle ansehen
Mbx Biosciences Inc Aktie (MBX) Neueste Nachrichten
MBX Biosciences, Inc. (NASDAQ:MBX) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Will MBX Biosciences Inc. stock benefit from upcoming earnings reports2025 Bull vs Bear & Real-Time Buy Zone Alerts - ulpravda.ru
Is MBX Biosciences Inc. stock positioned well for digital economyEarnings Growth Summary & High Yield Equity Trading Tips - ulpravda.ru
Will MBX Biosciences Inc. stock recover faster than marketJuly 2025 Sector Moves & Real-Time Market Trend Scan - ulpravda.ru
MBX Surge: Is It the Right Time? - timothysykes.com
MBX Biosciences (NASDAQ:MBX) Shares Gap UpTime to Buy? - MarketBeat
Monte Rosa Therapeutics, Ventyx Biosciences, United Microelectronics And Other Big Stocks Moving Higher On Wednesday - Benzinga
Will MBX Biosciences Inc. stock attract ESG investors2026 world cup usa national team third place match star players set piece tactics match prediction tactical review - ulpravda.ru
UBS initiates coverage on MBX Biosciences stock with Buy rating By Investing.com - Investing.com South Africa
UBS initiates coverage on MBX Biosciences stock with Buy rating - Investing.com
MBX Biosciences (NASDAQ:MBX) Trading Down 8.4%Here's Why - MarketBeat
Power Grid Corporation of India Limited Forms Bullish Flag Upside AheadGlobal Trade Effects & Free Trading Psychology Coaching - earlytimes.in
Commit To Purchase Mbx Biosciences At $20, Earn 25% Using Options - Nasdaq
MBX Biosciences (NASDAQ:MBX) Stock Price Down 5.8%Here's What Happened - MarketBeat
MBX Biosciences initiated with a sell at Goldman Sachs - MSN
MBX Biosciences (NASDAQ:MBX) Reaches New 12-Month HighStill a Buy? - MarketBeat
Mbx Biosciences stock hits all-time high of 34.85 USD By Investing.com - Investing.com India
MBX Biosciences (NASDAQ:MBX) Stock Price Up 10.8%Still a Buy? - MarketBeat
Mbx Biosciences stock hits all-time high of 34.85 USD - Investing.com
MBX Biosciences price target raised to $50 from $45 at Stifel - MSN
Take Profit: Will MBX Biosciences Inc stock keep outperforming rivalsJuly 2025 Pullbacks & Capital Efficiency Focused Ideas - moha.gov.vn
MBX Biosciences, Inc.(NasdaqGS:MBX) added to S&P Pharmaceuticals Select Industry Index - marketscreener.com
MBX Biosciences, Inc.(NasdaqGS: MBX) added to NASDAQ Biotechnology Index - marketscreener.com
Dip Buying: Will MBX Biosciences Inc stock keep outperforming rivalsJuly 2025 Intraday Action & Stock Portfolio Risk Control - moha.gov.vn
MBX Biosciences (NASDAQ:MBX) Upgraded at Wall Street Zen - MarketBeat
How sustainable is MBX Biosciences Inc. stock dividend payoutPortfolio Profit Report & Safe Entry Point Alerts - Улправда
Stifel maintains MBX Biosciences (MBX) buy recommendation - MSN
MBX Biosciences stock price target raised to $50 by Stifel on strong trial data By Investing.com - Investing.com Nigeria
Stifel Maintains MBX Biosciences (MBX) Buy Recommendation - Nasdaq
MBX Biosciences stock price target raised to $50 by Stifel on strong trial data - Investing.com South Africa
Aug Technicals: Will MBX Biosciences Inc. stock attract ESG investorsMarket Activity Recap & AI Enhanced Trading Alerts - Улправда
Is MBX Biosciences Inc. stock undervalued vs historical averagesJuly 2025 Sector Moves & High Accuracy Trade Signal Alerts - Улправда
S P Trends: What catalysts could drive MBX Biosciences Inc stock higherEarnings Growth Summary & Free Weekly Watchlist of Top Performers - moha.gov.vn
MBX Biosciences (MBX) faces platform validation challenge as near-term hypoglycemia data catalyst in Q2 2026 may lack differentiation - MSN
MBX Biosciences, Inc. (NASDAQ:MBX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
MBX Biosciences (MBX) Faces Platform Validation Challenge as Near-Term Hypoglycemia Data Catalyst in Q2 2026 May Lack Differentiation - Finviz
MBX Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13 - The Manila Times
20 Stocks That Will Double in 2026 - Insider Monkey
EcoR1 Capital LLC Lowers Holdings in MBX Biosciences, Inc. $MBX - MarketBeat
MBX Biosciences (NASDAQ:MBX) Lowered to Sell Rating by Wall Street Zen - MarketBeat
Walleye Capital LLC Increases Stock Holdings in MBX Biosciences, Inc. $MBX - MarketBeat
MBX Biosciences: Testing 2026 May Deliver Another Year Of Share Price Gains - Seeking Alpha
MBX Biosciences, Inc. $MBX Stake Increased by Stempoint Capital LP - MarketBeat
MBX Biosciences (NASDAQ:MBX) Shares Down 5.6%Should You Sell? - MarketBeat
Finanzdaten der Mbx Biosciences Inc-Aktie (MBX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Mbx Biosciences Inc-Aktie (MBX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Hawryluk P. Kent | President & CEO |
Oct 20 '25 |
Buy |
13.64 |
20,000 |
272,790 |
468,277 |
| Hoerter Steven L. | Director |
Oct 17 '25 |
Buy |
13.25 |
20,000 |
264,984 |
20,000 |
| Heron Patrick J | Director |
Sep 26 '25 |
Buy |
18.00 |
666,666 |
11,999,988 |
5,219,440 |
| Pescovitz Ora H. | Director |
Apr 08 '25 |
Buy |
5.89 |
7,693 |
45,312 |
24,329 |
| GORDON CARL L | Director |
Feb 18 '25 |
Buy |
10.84 |
143,170 |
1,551,963 |
3,255,000 |
| GORDON CARL L | Director |
Feb 14 '25 |
Buy |
9.87 |
47,502 |
468,793 |
3,205,930 |
| ORBIMED ADVISORS LLC | Director |
Feb 18 '25 |
Buy |
10.84 |
143,170 |
1,551,963 |
3,255,000 |
| ORBIMED ADVISORS LLC | Director |
Feb 14 '25 |
Buy |
9.87 |
47,502 |
468,793 |
3,205,930 |
| Hawryluk P. Kent | President & CEO |
Feb 04 '25 |
Buy |
10.69 |
50,000 |
534,500 |
448,277 |
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):